Abiopharma

Wiley Acquires Emerald, Expanding Research Scale and Deepening Proprietary Content Across the AI-Driven Knowledge Economy

Gilead’s Livdelzi® (Seladelpar) Delivers Statistically Significant Composite ALP Normalization in Phase 3 IDEAL Trial in Primary Biliary Cholangitis (PBC)

Insperity Earns 2026 Great Place to Work Certification™, Reinforcing Commitment to People-First Culture

Inventiva annonce une optimisation globale de sa structurefinancière, comprenant un financement obligataire et une offre dAmerican Depositary Shares, en prévision de la publication attendue des résultats de lessai de phase 3

Inventiva Announces a Comprehensive Capital Structure Optimization including Debt and Equity Financing in Advance of the Anticipated Phase 3 Readout

Orion to Present at Singular Research’s Las Vegas Invitational Conference

ZenaTech completa su 23.ª adquisición de Drone como Servicio y amplía su presencia en el corredor de crecimiento del sureste de Denver, Colorado

Convening of a special meeting for 9.7.26 – the company’s engagements in agreements regarding the club company, renewal of the employment terms of relatives, voting instrument

Celcuity’s Gedatolisib Combination Regimens Doubled the Likelihood of Survival without Disease Progression or Death Compared to Alpelisib plus Fulvestrant in the PIK3CA Mutant Cohort of the Pivotal Phase 3 VIKTORIA-1 Trial in Patients with HR+/HER2- Advanced Breast Cancer

Dorman Products, Inc. Announces Private Offering of $450 Million Of Senior Notes Due 2034